Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hubbard

Showing results (531-540 of 562) with videos related to

Pageof 57
Sort By:
Materials Science in Semiconductor Processing|June 19, 2015
Synthesis and characterization of [Zn(acetate)<sub>2</sub>(amine)<sub>x</sub>] compounds (x = 1 or 2) and their use as precursors to ZnOJesse S Hyslop, Amanda R Boydstun, Theron R Fereday, et al.
Blood|October 8, 2008
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host diseaseSydney X Lu, Onder Alpdogan, Janine Lin, et al.
The Lancet. Oncology|May 4, 2023
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 studyJohn H Strickler, Andrea Cercek, Salvatore Siena, et al.
Immunity|October 14, 2014
Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cellsVanessa M Hubbard-Lucey, Yusuke Shono, Katie Maurer, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Science Advances|May 18, 2022
First source-to-sink monitoring shows dense head controls sediment flux and runout in turbidity currentsEd L Pope, Matthieu J B Cartigny, Michael A Clare, et al.
Nature Communications|January 12, 2026
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysisJohn H Strickler, Andrea Cercek, Salvatore Siena, et al.
Nature Medicine|August 29, 2006
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantationJohannes L Zakrzewski, Adam A Kochman, Sydney X Lu, et al.
Science Advances|April 10, 2021
Niche and local geography shape the pangenome of wastewater- and livestock-associated EnterobacteriaceaeLiam P Shaw, Kevin K Chau, James Kavanagh, et al.
Investigational New Drugs|January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohortOluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.
Pageof 57

Showing results (531-540 of 562) with videos related to

Sort By:
Pageof 57
Materials Science in Semiconductor Processing|June 19, 2015
Synthesis and characterization of [Zn(acetate)<sub>2</sub>(amine)<sub>x</sub>] compounds (x = 1 or 2) and their use as precursors to ZnOJesse S Hyslop, Amanda R Boydstun, Theron R Fereday, et al.
Blood|October 8, 2008
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host diseaseSydney X Lu, Onder Alpdogan, Janine Lin, et al.
The Lancet. Oncology|May 4, 2023
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 studyJohn H Strickler, Andrea Cercek, Salvatore Siena, et al.
Immunity|October 14, 2014
Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cellsVanessa M Hubbard-Lucey, Yusuke Shono, Katie Maurer, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Science Advances|May 18, 2022
First source-to-sink monitoring shows dense head controls sediment flux and runout in turbidity currentsEd L Pope, Matthieu J B Cartigny, Michael A Clare, et al.
Nature Communications|January 12, 2026
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysisJohn H Strickler, Andrea Cercek, Salvatore Siena, et al.
Nature Medicine|August 29, 2006
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantationJohannes L Zakrzewski, Adam A Kochman, Sydney X Lu, et al.
Science Advances|April 10, 2021
Niche and local geography shape the pangenome of wastewater- and livestock-associated EnterobacteriaceaeLiam P Shaw, Kevin K Chau, James Kavanagh, et al.
Investigational New Drugs|January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohortOluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.
Pageof 57